Gregory Forlenza

Trials

Studies that name Gregory Forlenza as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:44 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06865989 · Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes

  Insulet Corporation · completed · Diabetes Mellitus, Type 1, Type 2 · study chair
• N/A
  NCT06177691 · Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

  Jaeb Center for Health Research · completed · Type1 Diabetes · study chair
• Early Ph1
  NCT05006040 · HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALL

  University of Colorado, Denver · terminated · High Risk Acute Lymphoblastic Leukemia · principal investigator
• Ph3
  NCT04233034 · Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

  Jaeb Center for Health Research · completed · Type1 Diabetes · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-11 21:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Cancer Research Training and Education Coordination
  P30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · fiscal years 2009 to 2026
  Named on NCT05006040